Presidential Award - High Impact Publication Honoree

Prize: Prize (including medals and awards)

Description

MERLIN: Two-Year Results of Brolucizumab in Participants with Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid
Awarded date2025

    Fingerprint